Neoadjuvant Tisleizumab(BGB-A317) for dMMR/MSI-H Non-late Stage CRC Patients Before Surgery
Sun Yat-sen University
Sun Yat-sen University
The Netherlands Cancer Institute
Consorzio Oncotech
Tianjin Medical University Cancer Institute and Hospital
Ruijin Hospital
Alliance for Clinical Trials in Oncology
ChineseAMS
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Fudan University
Fudan University
Huashan Hospital
Fifth Affiliated Hospital, Sun Yat-Sen University
Wuhan University
Peking Union Medical College Hospital
Royal Marsden NHS Foundation Trust
Shanghai Chest Hospital
Zhejiang Cancer Hospital
Sun Yat-sen University
Institute of Oncology Ljubljana
Velindre NHS Trust
National Cancer Institute (NCI)
Zhejiang Cancer Hospital
Shenzhen SiBiono GeneTech Co.,Ltd
Kyoto University Hospital
Hospital Authority, Hong Kong
Soroka University Medical Center
Gustave Roussy, Cancer Campus, Grand Paris